Mayne Agrees Deal For TherapeuticsMD’s US Women’s Health Portfolio

The Cash-Strapped Firms Hope The Deal Will Improve Their Fortunes

 
• By Rosalind Rei

Mayne Pharma enters an exclusive US license agreement with TherapeuticsMD for the latter’s women’s health portfolio. Whether the deal will boost their precarious finances is an open question.

Closeup of doctor applying stethoscope to pregnant woman's belly
The US women's health market has been a strategic priority for Mayne • Source: Shutterstock

More from Deals

More from Business